A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis

This study has been completed.

Study NCT00077870 Information provided by Genentech

First Received: February 12, 2004 Last Updated: September 1, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given